A carregar...
Use of the Intratumoural Anticancer Drug Tigilanol Tiglate in Two Horses
Tigilanol tiglate is a novel small molecule approved as a veterinary pharmaceutical in Europe for intratumoural treatment of non-metastatic, non-resectable canine mast cell tumors. The drug has a “tumor agnostic” mode of action associated with induction of an acute inflammatory response at the treat...
Na minha lista:
| Publicado no: | Front Vet Sci |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7509040/ https://ncbi.nlm.nih.gov/pubmed/33033726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fvets.2020.00639 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|